Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis-Reference-Cited by-同舟云学术

Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis

Published:2021-01 Issue: Volume:296 Page:100263
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Taudte Nadine,Linnert Miriam^ORCID,Rahfeld Jens-Ulrich,Piechotta Anke,Ramsbeck Daniel^ORCID,Buchholz Mirko,Kolenko Petr^ORCID,Parthier Christoph,Houston John A.,Veillard Florian,Eick Sigrun^ORCID,Potempa Jan,Schilling Stephan,Demuth Hans-Ulrich,Stubbs Milton T.^ORCID

Funder

National Institute of Dental and Craniofacial Research

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference70 articles.

1. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: A call for global action;Tonetti;J. Clin. Periodontol.,2017

2. Microbial complexes in subgingival plaque;Socransky;J. Clin. Periodontol.,1998

3. Periodontitis: A polymicrobial disruption of host homeostasis;Darveau;Nat. Rev. Microbiol.,2010

4. Host responses in the link between periodontitis and rheumatoid arthritis;Kobayashi;Curr. Oral Health Rep.,2015

5. The keystone-pathogen hypothesis;Hajishengallis;Nat. Rev. Microbiol.,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current research progress on Prevotella intermedia and associated diseases;Critical Reviews in Microbiology;2024-08-14

2. Metal Ion Binding to Human Glutaminyl Cyclase: A Structural Perspective;International Journal of Molecular Sciences;2024-07-29

3. The Bacteroidetes Q-rule and glutaminyl cyclase activity increase the stability of extracytoplasmic proteins;mBio;2023-10-31

4. Therapeutic potential of glutaminyl cyclases: Current status and emerging trends;Drug Discovery Today;2023-10

5. Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease;Frontiers in Aging Neuroscience;2023-08-03